PortfoliosLab logo
Apyx Medical Corporation (APYX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US03837C1062

CUSIP

03837C106

IPO Date

Jan 1, 1987

Highlights

Market Cap

$66.52M

EPS (TTM)

-$0.54

Total Revenue (TTM)

$47.29M

Gross Profit (TTM)

$24.39M

EBITDA (TTM)

-$14.41M

Year Range

$0.76 - $1.95

Target Price

$4.00

Short %

0.73%

Short Ratio

3.60

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Apyx Medical Corporation

Popular comparisons:
APYX vs. GHC
Popular comparisons:

Performance

Performance Chart


Loading data...

S&P 500

Returns By Period

Apyx Medical Corporation (APYX) returned 1.27% year-to-date (YTD) and 0.00% over the past 12 months. Over the past 10 years, APYX returned -5.10% annually, underperforming the S&P 500 benchmark at 10.84%.


APYX

YTD

1.27%

1M

70.21%

6M

-5.33%

1Y

0.00%

3Y*

-36.57%

5Y*

-18.46%

10Y*

-5.10%

^GSPC (Benchmark)

YTD

0.52%

1M

6.32%

6M

-1.44%

1Y

12.25%

3Y*

12.45%

5Y*

14.20%

10Y*

10.84%

*Annualized

Monthly Returns

The table below presents the monthly returns of APYX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-8.86%0.69%-5.52%-24.09%53.85%1.27%
2024-14.50%-6.25%-35.24%5.15%15.38%-18.79%1.49%-2.21%-6.77%-5.65%37.61%-1.86%-39.69%
202324.79%11.30%-11.38%18.06%86.18%-20.54%11.13%-16.64%-31.33%-28.44%3.06%11.02%11.97%
2022-10.30%-12.00%-35.47%-42.27%61.01%-3.46%61.43%-39.43%-21.64%11.36%-64.80%32.95%-81.75%
202129.03%12.49%-7.56%4.87%-3.36%5.31%-12.71%31.22%17.27%3.25%-6.08%-4.54%78.06%
2020-10.28%-20.29%-40.66%-5.29%30.59%25.00%-19.10%2.23%2.61%27.81%27.08%-5.88%-14.89%
201933.80%-19.03%-10.11%-20.92%20.84%11.44%7.74%-1.80%-4.78%-2.51%20.91%6.02%30.56%
2018-8.46%3.78%20.24%17.51%12.32%10.97%11.03%10.56%32.96%-25.77%34.16%-8.35%149.23%
20175.29%-15.61%-16.30%1.12%-23.33%19.32%2.43%-5.93%42.02%15.38%-24.87%-11.26%-27.58%
20164.76%-14.09%-11.64%17.96%-19.29%3.14%12.80%122.16%26.76%5.76%-22.14%-16.32%70.95%
2015-3.53%-4.79%-29.29%29.62%-6.71%-3.46%-17.20%-4.76%-11.36%-2.56%2.11%8.25%-42.93%
201429.30%13.31%23.81%1.28%16.96%-21.43%7.99%8.16%-5.90%-1.25%-0.36%-6.27%71.16%
Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of APYX is 53, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of APYX is 5353
Overall Rank
The Sharpe Ratio Rank of APYX is 4949
Sharpe Ratio Rank
The Sortino Ratio Rank of APYX is 6060
Sortino Ratio Rank
The Omega Ratio Rank of APYX is 5757
Omega Ratio Rank
The Calmar Ratio Rank of APYX is 5050
Calmar Ratio Rank
The Martin Ratio Rank of APYX is 5151
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Apyx Medical Corporation (APYX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Apyx Medical Corporation Sharpe ratios as of May 30, 2025 (values are recalculated daily):

  • 1-Year: 0.00
  • 5-Year: -0.19
  • 10-Year: -0.06
  • All Time: -0.01

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Apyx Medical Corporation compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

Dividend History


Apyx Medical Corporation doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Apyx Medical Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Apyx Medical Corporation was 94.99%, occurring on Apr 8, 2025. The portfolio has not yet recovered.

The current Apyx Medical Corporation drawdown is 90.80%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-94.99%Nov 23, 2021846Apr 8, 2025
-86.58%Sep 1, 1995691Jul 15, 1999743Sep 9, 20031434
-83.88%Dec 28, 20062367May 31, 20161166Jan 15, 20213533
-51.47%Nov 17, 2003460Sep 20, 2005153May 1, 2006613
-26.83%Aug 2, 200612Aug 17, 200647Oct 24, 200659
Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Apyx Medical Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Apyx Medical Corporation, comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 16.7% positive surprise.


-0.30-0.25-0.20-0.15-0.10-0.0520212022202320242025
-0.10
-0.12
Actual
Estimate

Valuation

The Valuation section provides an overview of how Apyx Medical Corporation is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for APYX relative to other companies in the Medical Devices industry. Currently, APYX has a P/S ratio of 1.4. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for APYX in comparison with other companies in the Medical Devices industry. Currently, APYX has a P/B value of 6.0. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items